Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,248
datasets available to search
ShareScore release 0.9.0
Dataset results
2,248 results for “squamous cell carcinoma”
Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT02524275. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the Esophagus
ClinicalTrials.gov study NCT03785496. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00392665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
ClinicalTrials.gov study NCT01824823. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)
ClinicalTrials.gov study NCT05459129. IPD Sharing: YES. Countries: 3. Publications: 0.
Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)
ClinicalTrials.gov study NCT04169074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06046482. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)
ClinicalTrials.gov study NCT04808999. IPD Sharing: NO. Countries: 1. Publications: 0.
Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
ClinicalTrials.gov study NCT01054625. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)
ClinicalTrials.gov study NCT00073450. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04936841. IPD Sharing: NO. Countries: 1. Publications: 0.
Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01592721. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00184028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003)
ClinicalTrials.gov study NCT02920476. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck
ClinicalTrials.gov study NCT01285635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT01468896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01412229. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT04665843. IPD Sharing: YES. Countries: 13. Publications: 0.
Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)
ClinicalTrials.gov study NCT03875859. IPD Sharing: NO. Countries: 1. Publications: 0.
AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04058145. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.